NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
24/02/2026
Voltar para busca
Dado oficial do USPTO
BIOSYNTH CARBOSYNTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
25/02/2026
Tipo de marca
Mista
Classes Nice
1, 5
Data de depósito
23/07/2019
Data de registro
03/03/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/02/2026
Última transação
25/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Primeiro uso
01/07/2019
Primeiro uso no comércio
01/07/2019
Código do desenho
3
Tipo de titular
03
Localização do titular
Staad, CH
Examinador
MOLINOFF, JEFFREY S.
Localização atual
Historical data usage
Descrição da marca
The mark consists of the stylized word "BIOSYNTH" in blue on top of a blue rectangle with the stylized word "CARBOSYNTH" in white inside the rectangle with a grey line underneath the rectangle.
Titulares e representantes
Titulares
Biosynth AG
Representantes
Tara Reedy Sliva DENTONS US LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemicals and organic chemicals used as enzyme substratesenzyme inducersaminoglutethimidescarbamazepinesgriseofulvinsprimidonesenzyme inactivatorscultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposesfor use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
Classe 5
Medicinal preparationsphotosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as a culture media for cultures of microorganisms for medical usefor the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposesfor Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosiscoronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposesfor novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposesimmunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposesfor medical detectionidentification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposesfor medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposesfor medical detection of pathogenic bacteriavarious strains of ListeriaClostridiumBacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposesfor the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureusin particular for Methicillin-resistant Staphylococcus aureus (MRSA)
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
24/02/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
27/01/2026
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
23/01/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/01/2026
E815
TEAS SECTION 8 & 15 RECEIVED
20/10/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/12/2019
PUBO
PUBLISHED FOR OPPOSITION
17/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/11/2019
ALIE
ASSIGNED TO LIE
07/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/10/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/09/2019
GNRT
NON-FINAL ACTION E-MAILED
05/09/2019
CNRT
NON-FINAL ACTION WRITTEN
05/09/2019
DOCK
ASSIGNED TO EXAMINER
05/09/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/08/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/07/2019
NWAP
NEW APPLICATION ENTERED
26/07/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOSYNTH CARBOSYNTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.